Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J FORMAN

Showing results (761-770 of 1,290) with videos related to

Pageof 129
Sort By:
Immunology|September 1, 1986
Synergy between interleukin-2 and a second factor in the long-term growth of human T cellsB J Mills, J E Shively, P S Mitsky, et al.
Fertility and Sterility|December 21, 2013
The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screeningJason M Franasiak, Eric J Forman, Kathleen H Hong, et al.
Blood|May 22, 2012
Brentuximab vedotin enables successful reduced-intensity allogeneic hematopoietic cell transplantation in patients with relapsed or refractory Hodgkin lymphomaRobert Chen, Joycelynne M Palmer, Sandra H Thomas, et al.
Leukemia|April 18, 2002
Primary myelodysplasia occurring in adults under 50 years old: a clinicopathologic study of 52 patientsK L Chang, M R O'Donnell, M L Slovak, et al.
Blood|April 1, 1991
Amplification by the polymerase chain reaction of hypervariable regions of the human genome for evaluation of chimerism after bone marrow transplantationL Ugozzoli, P Yam, L D Petz, et al.
Molecular Cancer Therapeutics|April 5, 2015
CD30 Downregulation, MMAE Resistance, and MDR1 Upregulation Are All Associated with Resistance to Brentuximab VedotinRobert Chen, Jessie Hou, Edward Newman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 23, 2011
High-dose therapy and autologous hematopoietic cell transplantation in peripheral T cell lymphoma (PTCL): analysis of prognostic factorsAuayporn Nademanee, Joycelynne M Palmer, Leslie Popplewell, et al.
Blood|September 25, 2004
Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomasAmrita Krishnan, Arturo Molina, John Zaia, et al.
Blood|April 15, 1993
A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first remission: a Southwest Oncology Group studyK G Blume, K J Kopecky, J P Henslee-Downey, et al.
Cancer|June 19, 2009
Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantationStephanie Campbell, Can-Lan Sun, Seira Kurian, et al.
Pageof 129

Showing results (761-770 of 1,290) with videos related to

Sort By:
Pageof 129
Immunology|September 1, 1986
Synergy between interleukin-2 and a second factor in the long-term growth of human T cellsB J Mills, J E Shively, P S Mitsky, et al.
Fertility and Sterility|December 21, 2013
The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screeningJason M Franasiak, Eric J Forman, Kathleen H Hong, et al.
Blood|May 22, 2012
Brentuximab vedotin enables successful reduced-intensity allogeneic hematopoietic cell transplantation in patients with relapsed or refractory Hodgkin lymphomaRobert Chen, Joycelynne M Palmer, Sandra H Thomas, et al.
Leukemia|April 18, 2002
Primary myelodysplasia occurring in adults under 50 years old: a clinicopathologic study of 52 patientsK L Chang, M R O'Donnell, M L Slovak, et al.
Blood|April 1, 1991
Amplification by the polymerase chain reaction of hypervariable regions of the human genome for evaluation of chimerism after bone marrow transplantationL Ugozzoli, P Yam, L D Petz, et al.
Molecular Cancer Therapeutics|April 5, 2015
CD30 Downregulation, MMAE Resistance, and MDR1 Upregulation Are All Associated with Resistance to Brentuximab VedotinRobert Chen, Jessie Hou, Edward Newman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 23, 2011
High-dose therapy and autologous hematopoietic cell transplantation in peripheral T cell lymphoma (PTCL): analysis of prognostic factorsAuayporn Nademanee, Joycelynne M Palmer, Leslie Popplewell, et al.
Blood|September 25, 2004
Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomasAmrita Krishnan, Arturo Molina, John Zaia, et al.
Blood|April 15, 1993
A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first remission: a Southwest Oncology Group studyK G Blume, K J Kopecky, J P Henslee-Downey, et al.
Cancer|June 19, 2009
Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantationStephanie Campbell, Can-Lan Sun, Seira Kurian, et al.
Pageof 129